Noel Pauli will present an overview of Adimab's in vivo platform and its capabilities.

William Roach will share how to apply Adimab's diverse tools for novel T cell engagers.

Garrett Rappazzo will present on Adimab's approach to pHLA-targeting therapeutics.

Adimab will be available for partnering meetings to discuss new and ongoing projects.

The Adimab team will present on TCEs, developability, peptides, and more as they take the stage and chair sessions.